Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Menarini Silicon Biosystems S P A currently has 3 pending office actions in the Chemistry & Materials technology area. These actions are spread across 3 distinct examiners and 3 distinct art units. HUANG, MICKEY NMN is the busiest examiner, with 1 pending office action. The distribution of 3 pending office actions across 3 distinct art units suggests a diverse range of technical subject matter within the portfolio.
Because each of the 3 distinct examiners handles 1 pending office action, the company faces a variety of examiner perspectives. This distribution requires the company to manage 3 distinct examiner relationships simultaneously. The lack of concentration among examiners or art units indicates that the company's current prosecution is not localized under any single regulatory group.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUANG, MICKEY NMN | 1 | 59.6% | +49.2% |
| HANDY, DWAYNE K | 1 | 62.6% | +25.1% |
| XIAO, YAN | 1 | 67.3% | +52.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18562149 | METHOD AND MICROFLUIDIC SYSTEM FOR THE ISOLATION OF PARTICLES | HUANG, MICKEY NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18562149 | METHOD AND MICROFLUIDIC SYSTEM FOR THE ISOLATION OF PARTICLES | HUANG, MICKEY NMN | — |
| 18024338 | SYSTEM, KIT, METHOD AND PROCESS FOR HANDLING A SAMPLE | HANDY, DWAYNE K | — |
| 18063678 | METHOD OF ISOLATING CIRCULATING TUMOR CELLS | XIAO, YAN | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1798 | 1 |
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18562149 | METHOD AND MICROFLUIDIC SYSTEM FOR THE ISOLATION OF PARTICLES | HUANG, MICKEY NMN | 1758 | §102§103 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18024338 | SYSTEM, KIT, METHOD AND PROCESS FOR HANDLING A SAMPLE | HANDY, DWAYNE K | 1798 | §103 | Final Rejection | — | Pending | Mar 02, 2023 |
| 18063678 | METHOD OF ISOLATING CIRCULATING TUMOR CELLS | XIAO, YAN | 1642 | DP | Non-Final OA | — | Pending | Dec 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial